<?xml version="1.0" ?>
<proxyVoteTable xmlns="http://www.sec.gov/edgar/document/npxproxy/informationtable">
  <proxyTable>
    <issuerName>PLUS THERAPEUTICS, INC.</issuerName>
    <cusip>72941H509</cusip>
    <meetingDate>08/07/2025</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>598593</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>598593</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PLUS THERAPEUTICS, INC.</issuerName>
    <cusip>72941H509</cusip>
    <meetingDate>08/07/2025</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>194710</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>194710</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CAPSTONE ENERGY+, INC.</issuerName>
    <cusip>14067D607</cusip>
    <meetingDate>08/12/2025</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>1356765</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>1356765</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CAPSTONE ENERGY+, INC.</issuerName>
    <cusip>14067D607</cusip>
    <meetingDate>08/12/2025</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>443235</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>443235</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>GRACE THERAPEUTICS, INC</issuerName>
    <cusip>00439U104</cusip>
    <meetingDate>09/12/2025</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>711017</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>711017</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>GRACE THERAPEUTICS, INC</issuerName>
    <cusip>00439U104</cusip>
    <meetingDate>09/12/2025</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>254877</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>254877</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>SANDISK CORPORATION</issuerName>
    <cusip>80004C200</cusip>
    <meetingDate>11/18/2025</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>148684</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>148684</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>SANDISK CORPORATION</issuerName>
    <cusip>80004C200</cusip>
    <meetingDate>11/18/2025</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>24213</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>24213</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>SANDISK CORPORATION</issuerName>
    <cusip>80004C200</cusip>
    <meetingDate>11/18/2025</meetingDate>
    <voteDescription>14A Executive Compensation Vote Frequency</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>148684</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>1</howVoted>
        <sharesVoted>148684</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>SANDISK CORPORATION</issuerName>
    <cusip>80004C200</cusip>
    <meetingDate>11/18/2025</meetingDate>
    <voteDescription>14A Executive Compensation Vote Frequency</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>24213</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>1</howVoted>
        <sharesVoted>24213</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LIGHTPATH TECHNOLOGIES, INC.</issuerName>
    <cusip>532257805</cusip>
    <meetingDate>12/17/2025</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>518150</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>518150</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LIGHTPATH TECHNOLOGIES, INC.</issuerName>
    <cusip>532257805</cusip>
    <meetingDate>12/17/2025</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>203796</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>203796</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>POLYPID LTD</issuerName>
    <cusip>M8001Q126</cusip>
    <meetingDate>02/04/2026</meetingDate>
    <voteDescription>14A Extraordinary Transaction Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>420068</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>420068</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>POLYPID LTD</issuerName>
    <cusip>M8001Q126</cusip>
    <meetingDate>02/04/2026</meetingDate>
    <voteDescription>14A Extraordinary Transaction Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>189203</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>189203</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>INTELLICHECK, INC.</issuerName>
    <cusip>45817G201</cusip>
    <meetingDate>05/07/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>1106082</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>1106082</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>INTELLICHECK, INC.</issuerName>
    <cusip>45817G201</cusip>
    <meetingDate>05/07/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>411167</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>411167</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>INTELLICHECK, INC.</issuerName>
    <cusip>45817G201</cusip>
    <meetingDate>05/07/2026</meetingDate>
    <voteDescription>14A Executive Compensation Vote Frequency</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>1106082</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>3</howVoted>
        <sharesVoted>1106082</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>INTELLICHECK, INC.</issuerName>
    <cusip>45817G201</cusip>
    <meetingDate>05/07/2026</meetingDate>
    <voteDescription>14A Executive Compensation Vote Frequency</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>411167</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>3</howVoted>
        <sharesVoted>411167</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PERSONALIS, INC.</issuerName>
    <cusip>71535D106</cusip>
    <meetingDate>05/12/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>1509177</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>1509177</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PERSONALIS, INC.</issuerName>
    <cusip>71535D106</cusip>
    <meetingDate>05/12/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>595095</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>595095</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BIODESIX, INC.</issuerName>
    <cusip>09075X207</cusip>
    <meetingDate>05/19/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>552726</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>552726</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BIODESIX, INC.</issuerName>
    <cusip>09075X207</cusip>
    <meetingDate>05/19/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>205602</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>205602</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BIODESIX, INC.</issuerName>
    <cusip>09075X207</cusip>
    <meetingDate>05/19/2026</meetingDate>
    <voteDescription>14A Executive Compensation Vote Frequency</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>552726</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>3</howVoted>
        <sharesVoted>552726</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BIODESIX, INC.</issuerName>
    <cusip>09075X207</cusip>
    <meetingDate>05/19/2026</meetingDate>
    <voteDescription>14A Executive Compensation Vote Frequency</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>205602</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>3</howVoted>
        <sharesVoted>205602</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LARIMAR THERAPEUTICS, INC.</issuerName>
    <cusip>517125100</cusip>
    <meetingDate>05/19/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>1396768</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>1396768</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LARIMAR THERAPEUTICS, INC.</issuerName>
    <cusip>517125100</cusip>
    <meetingDate>05/19/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>743111</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>743111</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LARIMAR THERAPEUTICS, INC.</issuerName>
    <cusip>517125100</cusip>
    <meetingDate>05/19/2026</meetingDate>
    <voteDescription>14A Executive Compensation Vote Frequency</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>1396768</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>3</howVoted>
        <sharesVoted>1396768</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LARIMAR THERAPEUTICS, INC.</issuerName>
    <cusip>517125100</cusip>
    <meetingDate>05/19/2026</meetingDate>
    <voteDescription>14A Executive Compensation Vote Frequency</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>743111</sharesVoted>
    <sharesOnLoan>860121</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>3</howVoted>
        <sharesVoted>743111</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ZEBRA TECHNOLOGIES CORPORATION</issuerName>
    <cusip>989207105</cusip>
    <meetingDate>05/19/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>408</sharesVoted>
    <sharesOnLoan>99440</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>408</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ZEBRA TECHNOLOGIES CORPORATION</issuerName>
    <cusip>989207105</cusip>
    <meetingDate>05/19/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>152</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>152</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>VERASTEM, INC.</issuerName>
    <cusip>92337C203</cusip>
    <meetingDate>05/21/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>575210</sharesVoted>
    <sharesOnLoan>1210961</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>575210</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>VERASTEM, INC.</issuerName>
    <cusip>92337C203</cusip>
    <meetingDate>05/21/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>213829</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>213829</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CASTLE BIOSCIENCES INC.</issuerName>
    <cusip>14843C105</cusip>
    <meetingDate>05/28/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>202844</sharesVoted>
    <sharesOnLoan>363860</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>202844</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CASTLE BIOSCIENCES INC.</issuerName>
    <cusip>14843C105</cusip>
    <meetingDate>05/28/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>23897</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>23897</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ESPERION THERAPEUTICS, INC.</issuerName>
    <cusip>29664W105</cusip>
    <meetingDate>05/28/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>2124584</sharesVoted>
    <sharesOnLoan>1485726</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>2124584</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ESPERION THERAPEUTICS, INC.</issuerName>
    <cusip>29664W105</cusip>
    <meetingDate>05/28/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>789690</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>789690</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>IDEAL POWER INC.</issuerName>
    <cusip>451622203</cusip>
    <meetingDate>06/03/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>861272</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>861272</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>IDEAL POWER INC.</issuerName>
    <cusip>451622203</cusip>
    <meetingDate>06/03/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>320424</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>320424</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LIPOCINE INC.</issuerName>
    <cusip>53630X203</cusip>
    <meetingDate>06/03/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>45825</sharesVoted>
    <sharesOnLoan>137143</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>45825</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LIPOCINE INC.</issuerName>
    <cusip>53630X203</cusip>
    <meetingDate>06/03/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>17032</sharesVoted>
    <sharesOnLoan>88823</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>17032</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>VANDA PHARMACEUTICALS INC.</issuerName>
    <cusip>921659108</cusip>
    <meetingDate>06/04/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>442363</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>442363</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>VANDA PHARMACEUTICALS INC.</issuerName>
    <cusip>921659108</cusip>
    <meetingDate>06/04/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>1418814</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>1418814</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>NLIGHT, INC.</issuerName>
    <cusip>65487K100</cusip>
    <meetingDate>06/05/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>247438</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>247438</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>NLIGHT, INC.</issuerName>
    <cusip>65487K100</cusip>
    <meetingDate>06/05/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>92562</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>92562</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>FENNEC PHARMACEUTICALS INC.</issuerName>
    <cusip>31447P100</cusip>
    <meetingDate>06/10/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>1487963</sharesVoted>
    <sharesOnLoan>5</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>1487963</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>FENNEC PHARMACEUTICALS INC.</issuerName>
    <cusip>31447P100</cusip>
    <meetingDate>06/10/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>543533</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>543533</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>FENNEC PHARMACEUTICALS INC.</issuerName>
    <cusip>31447P100</cusip>
    <meetingDate>06/10/2026</meetingDate>
    <voteDescription>14A Executive Compensation Vote Frequency</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>1487963</sharesVoted>
    <sharesOnLoan>5</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>3</howVoted>
        <sharesVoted>1487963</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>FENNEC PHARMACEUTICALS INC.</issuerName>
    <cusip>31447P100</cusip>
    <meetingDate>06/10/2026</meetingDate>
    <voteDescription>14A Executive Compensation Vote Frequency</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>543533</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>3</howVoted>
        <sharesVoted>543533</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ELUTIA INC.</issuerName>
    <cusip>05479K106</cusip>
    <meetingDate>06/11/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>2648966</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>2648966</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ELUTIA INC.</issuerName>
    <cusip>05479K106</cusip>
    <meetingDate>06/11/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>2458</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>2458</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ELUTIA INC.</issuerName>
    <cusip>05479K106</cusip>
    <meetingDate>06/11/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>941246</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>941246</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ELUTIA INC.</issuerName>
    <cusip>05479K106</cusip>
    <meetingDate>06/11/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>2580</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>2580</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ELUTIA INC.</issuerName>
    <cusip>05479K106</cusip>
    <meetingDate>06/11/2026</meetingDate>
    <voteDescription>14A Executive Compensation Vote Frequency</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>2648966</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>3</howVoted>
        <sharesVoted>2648966</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ELUTIA INC.</issuerName>
    <cusip>05479K106</cusip>
    <meetingDate>06/11/2026</meetingDate>
    <voteDescription>14A Executive Compensation Vote Frequency</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>2458</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>3</howVoted>
        <sharesVoted>2458</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ELUTIA INC.</issuerName>
    <cusip>05479K106</cusip>
    <meetingDate>06/11/2026</meetingDate>
    <voteDescription>14A Executive Compensation Vote Frequency</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>941246</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>3</howVoted>
        <sharesVoted>941246</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ELUTIA INC.</issuerName>
    <cusip>05479K106</cusip>
    <meetingDate>06/11/2026</meetingDate>
    <voteDescription>14A Executive Compensation Vote Frequency</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>2580</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>3</howVoted>
        <sharesVoted>2580</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ABEONA THERAPEUTICS INC.</issuerName>
    <cusip>00289Y206</cusip>
    <meetingDate>06/12/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>2259858</sharesVoted>
    <sharesOnLoan>701054</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>2259858</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ABEONA THERAPEUTICS INC.</issuerName>
    <cusip>00289Y206</cusip>
    <meetingDate>06/12/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>139088</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>139088</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PROTARA THERAPEUTICS, INC.</issuerName>
    <cusip>74365U107</cusip>
    <meetingDate>06/12/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>609243</sharesVoted>
    <sharesOnLoan>136330</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>609243</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PROTARA THERAPEUTICS, INC.</issuerName>
    <cusip>74365U107</cusip>
    <meetingDate>06/12/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>277160</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>277160</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PROTARA THERAPEUTICS, INC.</issuerName>
    <cusip>74365U107</cusip>
    <meetingDate>06/12/2026</meetingDate>
    <voteDescription>14A Executive Compensation Vote Frequency</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>609243</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>3</howVoted>
        <sharesVoted>609243</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PROTARA THERAPEUTICS, INC.</issuerName>
    <cusip>74365U107</cusip>
    <meetingDate>06/12/2026</meetingDate>
    <voteDescription>14A Executive Compensation Vote Frequency</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>277160</sharesVoted>
    <sharesOnLoan>136330</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>3</howVoted>
        <sharesVoted>277160</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>APREA THERAPEUTICS, INC.</issuerName>
    <cusip>03836J201</cusip>
    <meetingDate>06/16/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>645000</sharesVoted>
    <sharesOnLoan>20208</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>645000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>APREA THERAPEUTICS, INC.</issuerName>
    <cusip>03836J201</cusip>
    <meetingDate>06/16/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>263853</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>263853</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>APREA THERAPEUTICS, INC.</issuerName>
    <cusip>03836J201</cusip>
    <meetingDate>06/16/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>86480</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>86480</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>APREA THERAPEUTICS, INC.</issuerName>
    <cusip>03836J201</cusip>
    <meetingDate>06/16/2026</meetingDate>
    <voteDescription>14A Executive Compensation Vote Frequency</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>645000</sharesVoted>
    <sharesOnLoan>20208</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>3</howVoted>
        <sharesVoted>645000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>APREA THERAPEUTICS, INC.</issuerName>
    <cusip>03836J201</cusip>
    <meetingDate>06/16/2026</meetingDate>
    <voteDescription>14A Executive Compensation Vote Frequency</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>263853</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>3</howVoted>
        <sharesVoted>263853</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>APREA THERAPEUTICS, INC.</issuerName>
    <cusip>03836J201</cusip>
    <meetingDate>06/16/2026</meetingDate>
    <voteDescription>14A Executive Compensation Vote Frequency</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>86480</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>3</howVoted>
        <sharesVoted>86480</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ARDELYX, INC</issuerName>
    <cusip>039697107</cusip>
    <meetingDate>06/16/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>947700</sharesVoted>
    <sharesOnLoan>304304</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>947700</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ARDELYX, INC</issuerName>
    <cusip>039697107</cusip>
    <meetingDate>06/16/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>47996</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>47996</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ARDELYX, INC</issuerName>
    <cusip>039697107</cusip>
    <meetingDate>06/16/2026</meetingDate>
    <voteDescription>14A Executive Compensation Vote Frequency</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>947700</sharesVoted>
    <sharesOnLoan>304304</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>3</howVoted>
        <sharesVoted>947700</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ARDELYX, INC</issuerName>
    <cusip>039697107</cusip>
    <meetingDate>06/16/2026</meetingDate>
    <voteDescription>14A Executive Compensation Vote Frequency</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>47996</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>3</howVoted>
        <sharesVoted>47996</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>VUZIX CORPORATION</issuerName>
    <cusip>92921W300</cusip>
    <meetingDate>06/16/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>1174</sharesVoted>
    <sharesOnLoan>3294144</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>1174</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>VUZIX CORPORATION</issuerName>
    <cusip>92921W300</cusip>
    <meetingDate>06/16/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>436</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>436</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TALPHERA, INC.</issuerName>
    <cusip>00444T209</cusip>
    <meetingDate>06/22/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>3397489</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>3397489</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TALPHERA, INC.</issuerName>
    <cusip>00444T209</cusip>
    <meetingDate>06/22/2026</meetingDate>
    <voteDescription>14A Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>1264013</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>F</howVoted>
        <sharesVoted>1264013</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
</proxyVoteTable>
